Codinus, a local biodrug distribution company, said on May 21 it will make a cash tender offer of up to 15 billion to acquire a controlling stake in Hanseo Pharm.
Corinus will hold a 24.03% stake of Hanseo stocks.
The company also said this was part of its ambitious plan to advance into the domestic pharmaceutical market.
Last year, Codinus signed an exclusive agreement with Celltrion ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.